At my facility, the pharmacy and the Blood Bank collaborated in obtaining, storing, thawing, labeling and issuing the product. We did not have a standalone printer to create modification labels and our BB LIS considered it to be a pharmaceutical product. Pharmacy ordered the product after the patient's ABO type was available, shipped it to the BB for storage and thawing. Once thawed, the pharmacy picked up the product(s) and labeled the modified product and issued it to the patient infusion area. Fortunately, this has only come up twice in the last 8 years.